Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Brunner

Showing results (151-160 of 727) with videos related to

Pageof 73
Sort By:
Deutsche Medizinische Wochenschrift (1946)|April 30, 1976
[Frequency of chronic non-suppurative destructive cholangitis and primary biliary cirrhosis in comparison with other chronic inflammatory liver diseases]G Schmidt, J Kienle, D S Schmidt, et al.
Experimental Cell Research|April 1, 1992
Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitroA Meissauer, M D Kramer, V Schirrmacher, et al.
Archives of Neurology|December 1, 1985
High-dose intravenous methylprednisolone in myasthenia gravisE Arsura, N G Brunner, T Namba, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 1, 1997
Congenital conductive hearing loss in the lacrimoauriculodentodigital syndromeR J Ensink, C W Cremers, H G Brunner
Biomaterials, Medical Devices, and Artificial Organs|January 1, 1981
Properties of agarose-encapsulated adsorbents. II. Elimination of endogenous and exogenous phenolic compounds from human serumC J Holloway, K Harstick, G Brunner, et al.
Biomaterials, Medical Devices, and Artificial Organs|January 1, 1981
Properties of agarose-encapsulated adsorbents. I. Adsorption of digoxin from human serumC J Holloway, K Harstick, G Brunner, et al.
Molecular and Cellular Endocrinology|January 28, 1999
Activating and inactivating mutations in LH receptorsA P Themmen, J W Martens, H G Brunner
Tijdschrift Voor Kindergeneeskunde|February 1, 1993
[The Coffin-Siris syndrome. Description of 4 patients and a literature review]A F van Heyst, L A Kollée, H G Brunner
Neurology|October 1, 1971
Corticotropin therapy in myasthenia gravis: effects, indications, and limitationsT Namba, N G Brunner, M S Shapiro, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in managementN G Brunner, C L Berger, T Namba, et al.
Pageof 73

Showing results (151-160 of 727) with videos related to

Sort By:
Pageof 73
Deutsche Medizinische Wochenschrift (1946)|April 30, 1976
[Frequency of chronic non-suppurative destructive cholangitis and primary biliary cirrhosis in comparison with other chronic inflammatory liver diseases]G Schmidt, J Kienle, D S Schmidt, et al.
Experimental Cell Research|April 1, 1992
Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitroA Meissauer, M D Kramer, V Schirrmacher, et al.
Archives of Neurology|December 1, 1985
High-dose intravenous methylprednisolone in myasthenia gravisE Arsura, N G Brunner, T Namba, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 1, 1997
Congenital conductive hearing loss in the lacrimoauriculodentodigital syndromeR J Ensink, C W Cremers, H G Brunner
Biomaterials, Medical Devices, and Artificial Organs|January 1, 1981
Properties of agarose-encapsulated adsorbents. II. Elimination of endogenous and exogenous phenolic compounds from human serumC J Holloway, K Harstick, G Brunner, et al.
Biomaterials, Medical Devices, and Artificial Organs|January 1, 1981
Properties of agarose-encapsulated adsorbents. I. Adsorption of digoxin from human serumC J Holloway, K Harstick, G Brunner, et al.
Molecular and Cellular Endocrinology|January 28, 1999
Activating and inactivating mutations in LH receptorsA P Themmen, J W Martens, H G Brunner
Tijdschrift Voor Kindergeneeskunde|February 1, 1993
[The Coffin-Siris syndrome. Description of 4 patients and a literature review]A F van Heyst, L A Kollée, H G Brunner
Neurology|October 1, 1971
Corticotropin therapy in myasthenia gravis: effects, indications, and limitationsT Namba, N G Brunner, M S Shapiro, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in managementN G Brunner, C L Berger, T Namba, et al.
Pageof 73